Shingrix Reaches US Approval

Shingrix Reaches US Approval

GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.

China manufacturing facility grand launch

China manufacturing facility grand launch

China manufacturing facility to support the growing needs of the Asia-Pacific pharmaceutical and medical device markets that are supported with products developed by Tekni-Plex’s Colorite, Natvar and Action Technology business units.

Extreme Light Trapping New Technique

Extreme Light Trapping New Technique

Extreme Light Trapping, a new nanomaterials technique bends light, pushing the limit of thin-film absorption in solar and water-splitting applications. Light trapping describes the process of confining light to a given space, usually with the intent of converting it to other forms of energy.

Mesa Labs Acquisition News

Mesa Labs Acquisition News

Mesa Labs Acquires Sterilization Process Control Business October 5, 2017, Lakewood, Colorado – Mesa Laboratories, Inc. (NASDAQ:MLAB or Mesa Labs) (we, us, our, “Mesa Labs” or the “Company”) today announced the acquisition of all of the outstanding shares of SIMICON...